Overcoming obstacles in accessing unfunded oral chemotherapy

Physician experience and challenges

Dolly Han, Martina Trinkaus, Sophie Hogeveen, Muhammad Mamdani, Scott R. Berry, Raymond W. Jang, Jeffrey S Hoch, Christine Simmons

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Purpose: Previous studies have shown hematologists and medical oncologists may not accept the financial limits set by governing agencies on patient access to oral chemotherapy. The purpose of this study was to capture the methods physicians used to overcome barriers to accessing chemotherapeutic regimens for their patients. Methods: A total of 640 medical oncologists and hematologists across Canada were surveyed using a 13-item Web-based survey tool. The survey was delivered by e-mail with three follow-up reminders. After a response period of 3 months, results were collated and analyzed with descriptive statistics. Results: Of the 640 invitations, 568 were successfully delivered, and 183 responses were received (response rate, 32.0%). Among respondents, 101 treated solid malignancies (55.2%), 49 treated nonsolid malignancies (26.8%), and 33 treated both (18.0%). To overcome funding barriers, participating oncologists enrolled patients onto clinical trials (90.5%), used compassionate access programs (96.1%), and made special requests to government (91.8%). Other methods included writing false claims on forms to fit funding criteria for drugs (31.1%) and using leftover drug supplies (31.0%). Physicians felt their inability to obtain unfunded medications had a negative impact on their patients' clinical outcomes (56.0%) and psychosocial quality of life (73.0%). Only 28.5% of physicians contacted their governing body with concerns about oral chemotherapy funding. Conclusion: Canadian physicians use numerous methods to obtain unfunded oral chemotherapies, including falsifying claims on access forms and submitting special requests to government agencies. Further study is warranted to explore the disconnection between policymakers and physicians with regard to funding of oral chemotherapies.

Original languageEnglish (US)
Pages (from-to)188-196
Number of pages9
JournalJournal of Oncology Practice
Volume9
Issue number4
DOIs
StatePublished - Jul 2013
Externally publishedYes

Fingerprint

Physicians
Drug Therapy
Government Agencies
Postal Service
Pharmaceutical Preparations
Canada
Neoplasms
Quality of Life
Clinical Trials
Surveys and Questionnaires
Oncologists

ASJC Scopus subject areas

  • Oncology
  • Oncology(nursing)
  • Health Policy

Cite this

Han, D., Trinkaus, M., Hogeveen, S., Mamdani, M., Berry, S. R., Jang, R. W., ... Simmons, C. (2013). Overcoming obstacles in accessing unfunded oral chemotherapy: Physician experience and challenges. Journal of Oncology Practice, 9(4), 188-196. https://doi.org/10.1200/JOP.2012.000680

Overcoming obstacles in accessing unfunded oral chemotherapy : Physician experience and challenges. / Han, Dolly; Trinkaus, Martina; Hogeveen, Sophie; Mamdani, Muhammad; Berry, Scott R.; Jang, Raymond W.; Hoch, Jeffrey S; Simmons, Christine.

In: Journal of Oncology Practice, Vol. 9, No. 4, 07.2013, p. 188-196.

Research output: Contribution to journalArticle

Han, D, Trinkaus, M, Hogeveen, S, Mamdani, M, Berry, SR, Jang, RW, Hoch, JS & Simmons, C 2013, 'Overcoming obstacles in accessing unfunded oral chemotherapy: Physician experience and challenges', Journal of Oncology Practice, vol. 9, no. 4, pp. 188-196. https://doi.org/10.1200/JOP.2012.000680
Han, Dolly ; Trinkaus, Martina ; Hogeveen, Sophie ; Mamdani, Muhammad ; Berry, Scott R. ; Jang, Raymond W. ; Hoch, Jeffrey S ; Simmons, Christine. / Overcoming obstacles in accessing unfunded oral chemotherapy : Physician experience and challenges. In: Journal of Oncology Practice. 2013 ; Vol. 9, No. 4. pp. 188-196.
@article{ba1cb005a0774989abc3703a3b3ab0f1,
title = "Overcoming obstacles in accessing unfunded oral chemotherapy: Physician experience and challenges",
abstract = "Purpose: Previous studies have shown hematologists and medical oncologists may not accept the financial limits set by governing agencies on patient access to oral chemotherapy. The purpose of this study was to capture the methods physicians used to overcome barriers to accessing chemotherapeutic regimens for their patients. Methods: A total of 640 medical oncologists and hematologists across Canada were surveyed using a 13-item Web-based survey tool. The survey was delivered by e-mail with three follow-up reminders. After a response period of 3 months, results were collated and analyzed with descriptive statistics. Results: Of the 640 invitations, 568 were successfully delivered, and 183 responses were received (response rate, 32.0{\%}). Among respondents, 101 treated solid malignancies (55.2{\%}), 49 treated nonsolid malignancies (26.8{\%}), and 33 treated both (18.0{\%}). To overcome funding barriers, participating oncologists enrolled patients onto clinical trials (90.5{\%}), used compassionate access programs (96.1{\%}), and made special requests to government (91.8{\%}). Other methods included writing false claims on forms to fit funding criteria for drugs (31.1{\%}) and using leftover drug supplies (31.0{\%}). Physicians felt their inability to obtain unfunded medications had a negative impact on their patients' clinical outcomes (56.0{\%}) and psychosocial quality of life (73.0{\%}). Only 28.5{\%} of physicians contacted their governing body with concerns about oral chemotherapy funding. Conclusion: Canadian physicians use numerous methods to obtain unfunded oral chemotherapies, including falsifying claims on access forms and submitting special requests to government agencies. Further study is warranted to explore the disconnection between policymakers and physicians with regard to funding of oral chemotherapies.",
author = "Dolly Han and Martina Trinkaus and Sophie Hogeveen and Muhammad Mamdani and Berry, {Scott R.} and Jang, {Raymond W.} and Hoch, {Jeffrey S} and Christine Simmons",
year = "2013",
month = "7",
doi = "10.1200/JOP.2012.000680",
language = "English (US)",
volume = "9",
pages = "188--196",
journal = "Journal of Oncology Practice",
issn = "1554-7477",
publisher = "American Society of Clinical Oncology",
number = "4",

}

TY - JOUR

T1 - Overcoming obstacles in accessing unfunded oral chemotherapy

T2 - Physician experience and challenges

AU - Han, Dolly

AU - Trinkaus, Martina

AU - Hogeveen, Sophie

AU - Mamdani, Muhammad

AU - Berry, Scott R.

AU - Jang, Raymond W.

AU - Hoch, Jeffrey S

AU - Simmons, Christine

PY - 2013/7

Y1 - 2013/7

N2 - Purpose: Previous studies have shown hematologists and medical oncologists may not accept the financial limits set by governing agencies on patient access to oral chemotherapy. The purpose of this study was to capture the methods physicians used to overcome barriers to accessing chemotherapeutic regimens for their patients. Methods: A total of 640 medical oncologists and hematologists across Canada were surveyed using a 13-item Web-based survey tool. The survey was delivered by e-mail with three follow-up reminders. After a response period of 3 months, results were collated and analyzed with descriptive statistics. Results: Of the 640 invitations, 568 were successfully delivered, and 183 responses were received (response rate, 32.0%). Among respondents, 101 treated solid malignancies (55.2%), 49 treated nonsolid malignancies (26.8%), and 33 treated both (18.0%). To overcome funding barriers, participating oncologists enrolled patients onto clinical trials (90.5%), used compassionate access programs (96.1%), and made special requests to government (91.8%). Other methods included writing false claims on forms to fit funding criteria for drugs (31.1%) and using leftover drug supplies (31.0%). Physicians felt their inability to obtain unfunded medications had a negative impact on their patients' clinical outcomes (56.0%) and psychosocial quality of life (73.0%). Only 28.5% of physicians contacted their governing body with concerns about oral chemotherapy funding. Conclusion: Canadian physicians use numerous methods to obtain unfunded oral chemotherapies, including falsifying claims on access forms and submitting special requests to government agencies. Further study is warranted to explore the disconnection between policymakers and physicians with regard to funding of oral chemotherapies.

AB - Purpose: Previous studies have shown hematologists and medical oncologists may not accept the financial limits set by governing agencies on patient access to oral chemotherapy. The purpose of this study was to capture the methods physicians used to overcome barriers to accessing chemotherapeutic regimens for their patients. Methods: A total of 640 medical oncologists and hematologists across Canada were surveyed using a 13-item Web-based survey tool. The survey was delivered by e-mail with three follow-up reminders. After a response period of 3 months, results were collated and analyzed with descriptive statistics. Results: Of the 640 invitations, 568 were successfully delivered, and 183 responses were received (response rate, 32.0%). Among respondents, 101 treated solid malignancies (55.2%), 49 treated nonsolid malignancies (26.8%), and 33 treated both (18.0%). To overcome funding barriers, participating oncologists enrolled patients onto clinical trials (90.5%), used compassionate access programs (96.1%), and made special requests to government (91.8%). Other methods included writing false claims on forms to fit funding criteria for drugs (31.1%) and using leftover drug supplies (31.0%). Physicians felt their inability to obtain unfunded medications had a negative impact on their patients' clinical outcomes (56.0%) and psychosocial quality of life (73.0%). Only 28.5% of physicians contacted their governing body with concerns about oral chemotherapy funding. Conclusion: Canadian physicians use numerous methods to obtain unfunded oral chemotherapies, including falsifying claims on access forms and submitting special requests to government agencies. Further study is warranted to explore the disconnection between policymakers and physicians with regard to funding of oral chemotherapies.

UR - http://www.scopus.com/inward/record.url?scp=84887123686&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84887123686&partnerID=8YFLogxK

U2 - 10.1200/JOP.2012.000680

DO - 10.1200/JOP.2012.000680

M3 - Article

VL - 9

SP - 188

EP - 196

JO - Journal of Oncology Practice

JF - Journal of Oncology Practice

SN - 1554-7477

IS - 4

ER -